These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17163876)

  • 41. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do we have to rethink serologic markers used to diagnose hepatitis B infection?
    Roeckel IE
    Ann Clin Lab Sci; 1989; 19(6):397-400. PubMed ID: 2604376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Massive and multi-transfusions in polytraumatized patients: long-term serologic markers of hepatitis B, hepatitis C and AIDS].
    Schneck HJ; Dobler G; Hundelshausen B; Nathrath M; Drescher M
    Infusionstherapie; 1991 Oct; 18(5):248-55. PubMed ID: 1663086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti-core antibody in HBsAg negative subjects].
    Ferroni P; Quartodipalo ME; Zanetti AR
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can anti-HBc testing decrease the residual risk of transfusion-related HIV transmission?
    Fiedler H
    Vox Sang; 1991; 61(2):144-5. PubMed ID: 1763501
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter: Risk of transfusing blood containing anti-HBS.
    Fielder H
    Lancet; 1975 Feb; 1(7902):341. PubMed ID: 46488
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Scientific Section Coordinating Committee.
    Dodd RY; Popovsky MA
    Transfusion; 1991 Jun; 31(5):443-9. PubMed ID: 2048182
    [No Abstract]   [Full Text] [Related]  

  • 50. Non-B post-transfusion hepatitis with hepatitis B core antibodies in donor blood.
    Katchaki JN; Siem TH; Brouwer R
    N Engl J Med; 1982 Sep; 307(10):628-9. PubMed ID: 6810169
    [No Abstract]   [Full Text] [Related]  

  • 51. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B virus blood screening: unfinished agendas.
    Comanor L; Holland P
    Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Latent HBV infection in single blood donors].
    Fedorchenko SV; Zanevskaia LI; Burma NM; Borisevich OS; Balitskaia TE; Iurchenko LF; Martynovich TL
    Vopr Virusol; 2008; 53(3):23-5. PubMed ID: 18590131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus transmitted by HBsAg-negative blood containing anti-HBc.
    Hopkins R; Kane E; Robertson AE; Haase G
    Med Lab Sci; 1982 Jan; 39(1):61-2. PubMed ID: 7098783
    [No Abstract]   [Full Text] [Related]  

  • 56. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood.
    Vyas GN; Perkins HA
    N Engl J Med; 1982 Mar; 306(12):749-50. PubMed ID: 6801510
    [No Abstract]   [Full Text] [Related]  

  • 57. Is it a case of transfusion-transmitted acute HBV or reactivation of occult hepatitis B virus infection?
    Ozaslan E; Purnak T
    Transfus Med; 2010 Aug; 20(4):275. PubMed ID: 20534032
    [No Abstract]   [Full Text] [Related]  

  • 58. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy control of HB blood donor screening.
    Fiedler H
    Haematologia (Budap); 1983; 16(1-4):99-104. PubMed ID: 6679491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.